Pharma major Dr. Reddy’s Laboratories has entered into a partnership with Prestige BioPharma under which it will get exclusive rights to supply and commercialise the Singapore firm’s proposed trastuzumab biosimilar in select Latin America and Southeast Asian countries. CEO Lisa S. Park said the partnership with Dr. Reddy’s is for key Latin American and Southeast Asian markets. CEO – Branded …